{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:44:16Z","timestamp":1793659456967,"version":"4.5.1"},"reference-count":41,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>It is critical to characterize the natural history of albuminuria in patients with sickle cell anemia (SCA); however, these data are currently lacking and affecting evidence-based guidelines. We performed a natural history study of the development of pediatric albuminuria. We identified participants with hemoglobin SS\/SB0 thalassemia \u22655 years with albumin to creatinine ratio (ACR) measurements performed at a steady-state clinic visit. Participants were characterized as either persistent, intermittent, or never albuminuria. We determined the prevalence of persistent albuminuria, use of ACR \u2265100\u00a0mg\/g as a predictor, and variation in ACR measurements. We mirrored this study to determine the variation in albuminuria measurements in the SCA murine model. Among 355 participants with HbSS\/SB0 thalassemia with 1728 ACR measurements, we identified 17% with persistent and 13% with intermittent albuminuria. Thirteen percent of participants with persistent albuminuria developed an abnormal ACR before 10 years of age. A single ACR measurement \u2265100\u00a0mg\/g was associated with 55.5 times (95% confidence interval, 12.3-527) higher odds of having persistent albuminuria. Among participants with ACR \u2265100\u00a0mg\/g, we identified significant variability in the results of repeated measurements. The median ACR at the initial and next measurements were 175.8\u00a0mg\/g (interquartile range [IQR], 135-242) and 117.3\u00a0mg\/g (IQR, 64-292). The human variability in ACR was mirrored by \u223c20% variability in albuminuria in murine model. This evidence suggests adopting standards for repeating ACR measurements, consider screening for ACR before 10 years of age, and using an ACR &amp;gt;100\u00a0mg\/g as a risk factor for progression. Pediatric and murine renoprotective clinical trials need to consider the high variability in repeated ACR measurements.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010101","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T18:30:28Z","timestamp":1689013828000},"page":"6850-6858","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Natural history and variability in albuminuria in pediatric and murine sickle cell anemia"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3345-1580","authenticated-orcid":false,"given":"Malgorzata","family":"Kasztan","sequence":"first","affiliation":[{"name":"1Division of Pediatric Hematology Oncology, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Aban","sequence":"additional","affiliation":[{"name":"2Department of Biostatistics, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Baker","sequence":"additional","affiliation":[{"name":"3Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9535-2064","authenticated-orcid":false,"given":"Michael","family":"Ho","sequence":"additional","affiliation":[{"name":"3Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chibuzo","family":"Ilonze","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Hematology Oncology, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lebensburger","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Hematology Oncology, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"issue":"7","key":"2023112721011174800_bib1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MPH.0000000000002426","article-title":"Enuresis and hyperfiltration in children with sickle cell disease","volume":"44","author":"Zahr","year":"2022","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"3","key":"2023112721011174800_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bjh.12024","article-title":"High one year mortality in adults with sickle cell disease and end-stage renal disease","volume":"159","author":"McClellan","year":"2012","journal-title":"Br J Haematol"},{"issue":"2","key":"2023112721011174800_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.03940415","article-title":"Kidney disease among patients with sickle cell disease, hemoglobin SS and SC","volume":"11","author":"Drawz","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2023112721011174800_bib4","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.kint.2022.02.034","article-title":"Calculated versus measured albumin-creatinine ratio to predict kidney failure and death in people with chronic kidney disease","volume":"101","author":"Al-Wahsh","year":"2022","journal-title":"Kidney Int"},{"issue":"8","key":"2023112721011174800_bib5","doi-asserted-by":"crossref","first-page":"e2225821","DOI":"10.1001\/jamanetworkopen.2022.25821","article-title":"Association of albuminuria and regression of chronic kidney disease in adults with newly diagnosed moderate to severe chronic kidney disease","volume":"5","author":"Pasternak","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"22","key":"2023112721011174800_bib6","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2012.16817","article-title":"Age and association of kidney measures with mortality and end-stage renal disease","volume":"308","author":"Hallan","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"2023112721011174800_bib7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MPH.0b013e3180335081","article-title":"Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease","volume":"29","author":"McKie","year":"2007","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"4","key":"2023112721011174800_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02723586","article-title":"Microalbuminuria as a predictor of early glomerular injury in children with sickle cell disease","volume":"70","author":"Datta","year":"2003","journal-title":"Indian J Pediatr"},{"issue":"2","key":"2023112721011174800_bib9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/ndt\/gfm858","article-title":"Proteinuria in children with sickle cell disease","volume":"23","author":"Marsenic","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"2023112721011174800_bib10","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/bloodadvances.2019001378","article-title":"Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study","volume":"4","author":"Niss","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"2023112721011174800_bib11","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1111\/bjh.18494","article-title":"Patients with sickle cell disease who develop end-stage kidney disease continue to experience poor survival - a 19-year United States Renal Data System study","volume":"199","author":"Winer","year":"2022","journal-title":"Br J Haematol"},{"issue":"3","key":"2023112721011174800_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2215\/CJN.02720320","article-title":"Mortality and access to kidney transplantation in patients with sickle cell disease-associated kidney failure","volume":"16","author":"Bae","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"2023112721011174800_bib13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"23","key":"2023112721011174800_bib14","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1182\/bloodadvances.2019000916","article-title":"American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease","volume":"3","author":"Liem","year":"2019","journal-title":"Blood Adv"},{"issue":"23","key":"2023112721011174800_bib15","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1182\/bloodadvances.2019000883","article-title":"End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings","volume":"3","author":"Farrell","year":"2019","journal-title":"Blood Adv"},{"issue":"5339","key":"2023112721011174800_bib16","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1126\/science.278.5339.873","article-title":"Knockout-transgenic mouse model of sickle cell disease","volume":"278","author":"Ryan","year":"1997","journal-title":"Science"},{"issue":"9","key":"2023112721011174800_bib17","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/bloodadvances.2018028878","article-title":"Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice","volume":"3","author":"Kasztan","year":"2019","journal-title":"Blood Adv"},{"issue":"11","key":"2023112721011174800_bib18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"issue":"6","key":"2023112721011174800_bib19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1053\/j.ajkd.2013.06.016","article-title":"Day-to-day variability in spot urine albumin-creatinine ratio","volume":"62","author":"Naresh","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"2023112721011174800_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fped.2016.00106","article-title":"Changes in urine microalbumin-to-creatinine ratio in children with sickle cell disease over time","volume":"4","author":"Shatat","year":"2016","journal-title":"Front Pediatr"},{"issue":"1","key":"2023112721011174800_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.ajkd.2010.12.026","article-title":"Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community","volume":"58","author":"White","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2023112721011174800_bib22","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1002\/ajh.25329","article-title":"Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia","volume":"94","author":"Zahr","year":"2019","journal-title":"Am J Hematol"},{"issue":"3","key":"2023112721011174800_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1681\/ASN.2013090950","article-title":"The proximal tubule and albuminuria: really","volume":"25","author":"Dickson","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"2023112721011174800_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.kint.2015.11.007","article-title":"Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease","volume":"89","author":"Nielsen","year":"2016","journal-title":"Kidney Int"},{"issue":"6","key":"2023112721011174800_bib25","doi-asserted-by":"crossref","first-page":"C733","DOI":"10.1152\/ajpcell.00021.2017","article-title":"Hemoglobin inhibits albumin uptake by proximal tubule cells: implications for sickle cell disease","volume":"312","author":"Eshbach","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"2023112721011174800_bib26","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1681\/ASN.2014111126","article-title":"Six months of hydroxyurea reduces albuminuria in patients with sickle cell disease","volume":"27","author":"Bartolucci","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"2023112721011174800_bib27","doi-asserted-by":"crossref","first-page":"E520","DOI":"10.1002\/ajh.24810","article-title":"Losartan for the nephropathy of sickle cell anemia: a phase-2, multicenter trial","volume":"92","author":"Quinn","year":"2017","journal-title":"Am J Hematol"},{"issue":"8","key":"2023112721011174800_bib28","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","volume":"4","author":"DeBaun","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"2023112721011174800_bib29","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1542\/peds.109.3.526","article-title":"Health supervision for children with sickle cell disease","volume":"109","author":"Section on Hematology\/Oncology Committee on Genetics; American Academy of Pediatrics","year":"2002","journal-title":"Pediatrics"},{"issue":"1","key":"2023112721011174800_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"2023112721011174800_bib31","doi-asserted-by":"crossref","first-page":"e1062","DOI":"10.1097\/MPH.0000000000002103","article-title":"Transcranial Doppler screening in a current cohort of children with sickle cell anemia: results from the DISPLACE Study","volume":"43","author":"Kanter","year":"2021","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"4","key":"2023112721011174800_bib32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ajh.25390","article-title":"Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy","volume":"94","author":"Lebensburger","year":"2019","journal-title":"Am J Hematol"},{"issue":"3","key":"2023112721011174800_bib33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","article-title":"MYH9 and APOL1 are both associated with sickle cell disease nephropathy","volume":"155","author":"Ashley-Koch","year":"2011","journal-title":"Br J Haematol"},{"issue":"2","key":"2023112721011174800_bib34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/bjh.14842","article-title":"Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target","volume":"179","author":"Kormann","year":"2017","journal-title":"Br J Haematol"},{"issue":"1","key":"2023112721011174800_bib35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3324\/haematol.2016.154153","article-title":"APOL1, \u03b1-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia","volume":"102","author":"Saraf","year":"2017","journal-title":"Haematologica"},{"issue":"10","key":"2023112721011174800_bib36","doi-asserted-by":"crossref","first-page":"e0164364","DOI":"10.1371\/journal.pone.0164364","article-title":"Genetic modifiers of white blood cell count, albuminuria and glomerular filtration rate in children with sickle cell anemia","volume":"11","author":"Schaefer","year":"2016","journal-title":"PLoS One"},{"issue":"23","key":"2023112721011174800_bib37","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2023112721011174800_bib38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2215\/CJN.15161219","article-title":"APOL1 nephropathy: from genetics to clinical applications","volume":"16","author":"Friedman","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"2023112721011174800_bib39","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.3324\/haematol.2018.212779","article-title":"Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life","volume":"104","author":"Zahr","year":"2019","journal-title":"Haematologica"},{"issue":"suppl 1","key":"2023112721011174800_bib40","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1182\/blood-2021-149849","article-title":"A phase II, randomized, multicenter, open-label study evaluating the effect of crizanlizumab and standard of care (SoC) versus standard of care alone on renal function in patients with chronic kidney disease due to sickle cell nephropathy (STEADFAST)","volume":"138","author":"Saraf","year":"2021","journal-title":"Blood"},{"issue":"6","key":"2023112721011174800_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/ki.2009.501","article-title":"Major contribution of tubular secretion to creatinine clearance in mice","volume":"77","author":"Eisner","year":"2010","journal-title":"Kidney Int"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/22\/6850\/2109313\/blooda_adv-2023-010101-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/22\/6850\/2109313\/blooda_adv-2023-010101-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T21:02:35Z","timestamp":1701118955000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/22\/6850\/496802\/Natural-history-and-variability-in-albuminuria-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":41,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023,11,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010101","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]}}}